Krafte pharmaceuticals steroids

The HBS Kraft Precision Medicine Accelerator was established in 2016 with a $20 million endowment from the Robert and Myra Kraft Family Foundation, Inc. to speed precision medicine. The Accelerator is co-chaired by Kathy Giusti, founder of the Multiple Myeloma Research Foundation, and Richard Hamermesh, Harvard Senior Fellow, who work alongside a diverse team of health care and business visionaries. The Accelerator focuses on convening leaders, sharing best practices, identifying solutions, and disseminating knowledge.

Krafte pharmaceuticals steroids

krafte pharmaceuticals steroids

Media: